# Illumina, Inc. (ILMN) · Edgar & Edgarette company card

> Illumina (ILMN) saw revenue fall 0.7% in FY2025 to $4.3 billion, operating margin 18.6% against a -1.0% median for laboratory analytical instruments, equity 41.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1110803 · fiscal year ended 2025-12-28 · 5 audited years read · [page](https://www.pops4.com/boards/company/ILMN) · [JSON](https://www.pops4.com/boards/company/ILMN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $4.3B |
| Revenue growth, 1 year | -0.7% |
| Revenue growth per year | -1.0% |
| Operating margin | 18.6% (prior year -19.1%) |
| Net margin | 19.6% |
| Operating cash flow | $1.1B |
| Capital spending | $148M |
| Free cash flow | $931M |
| Cash | $1.4B |
| Long-term debt | — |
| Total assets | $6.6B |
| Total equity | $2.7B |
| Equity ÷ assets | 41.0% |
| Return on equity | 31.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 3.04 (safe zone)
- Piotroski F: 8 of 9 (strong)
- Beneish M: -2.51 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $4.3B (FY2025). Experience: revenue down 0.7% on the year, down 1.0% a year over 4 years; operating margin 18.6%, up from -19.1%. Soundness: equity 41.0% of assets, return on equity 31.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $3.5B and $5.1B next year (method v4.1: its own 5-year record of growth weighed at 57% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $3.0B to $5.9B. A statistical range, not company guidance. Against peers (12 filers, $50M+ revenue, laboratory analytical instruments): operating margin 18.6% against a -1.0% median; growth -0.7% against 1.1%.

Range logged 2026-10-14, receipt 088696d1eefe4784, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-06-23 ([filing](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000138/0001110803-26-000138-index.htm))

## Recent filings

- 10-Q · filed 2026-10-30 · [filing](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000207/0001110803-26-000207-index.htm)
- 8-K · filed 2026-10-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000202/0001110803-26-000202-index.htm)
- 8-K · filed 2026-10-13 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000195/0001110803-26-000195-index.htm)
- 8-K · filed 2026-08-17 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1110803/000119312526354010/0001193125-26-354010-index.htm)
- 8-K · filed 2026-08-13 · 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1110803/000095015726000888/0000950157-26-000888-index.htm)
- 8-K · filed 2026-08-12 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1110803/000119312526345802/0001193125-26-345802-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001110803.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1110803

## Cite

POPS4, Edgar & Edgarette: Illumina, Inc. (ILMN) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/ILMN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

